Reference Strains: The Foundation of Reliable GPT

Can you trust your Growth Promotion Testing result if you cannot trust the microorganism used to challenge it?

Growth Promotion Testing exists to answer a single question: will this batch of medium support the recovery and growth of the organisms it is designed to detect? It is the control that stands between your laboratory and a false negative — the quiet failure mode in which a contaminated sample is released as compliant because the medium never had the capacity to reveal the organism in the first place.

Yet GPT is only as defensible as the reference microorganism used to perform it.

And this is where many programmes are quietly exposed.

The reference strain is part of the measurement system — not a consumable

Under pharmacopoeial frameworks (USP <61>/<62>, Ph. Eur. 2.6.12/2.6.13, and the harmonised chapters governing microbial enumeration and specified organisms), GPT requires challenge organisms that are traceable to a recognised culture collection and are used within a controlled number of passages from the reference stock. This passage limit is not bureaucratic. Every subculture is an opportunity for genotypic and phenotypic drift — loss of virulence factors, altered growth kinetics, changes in colonial morphology, even loss of the very characteristics the medium is designed to select for. A strain more than five passages removed from its reference stock is, formally, no longer the reference strain. Any recovery data generated with it inherits that uncertainty.

This is why provenance matters as much as identity. Knowing you are working with Escherichia coli is not the same as knowing you are working with E. coli ATCC 8739, at a defined passage, with documented lineage back to the collection. The first is a species. The second is a controlled reference — and only the second belongs in a GPT programme.

Qualitative and quantitative challenges are not interchangeable

Where the pharmacopoeia calls for demonstration of growth (qualitative), the requirement is that the organism grows visibly and characteristically on the medium. Where it calls for a recovery ratio (quantitative), the inoculum must be controlled to a defined range — typically not more than 100 CFU — and recovery on the test medium compared against a validated reference, with an acceptance criterion (commonly a recovery factor within 0.5–2.0 of the reference). Applying a qualitative mindset to a quantitative requirement — or inoculating without controlling the challenge dose — is one of the most common findings in microbiology audits, and one of the hardest to defend after the fact.

Reference microorganisms available through Genesis

We supply reference strains from ATCC and NCTC — the two collections most widely recognised across regulatory and pharmacopoeial contexts — in formats matched to how your laboratory actually works:

• Quantitative preparations with a defined, certificate-backed CFU range, for recovery studies and quantitative GPT

• Qualitative preparations for growth-demonstration challenges

• Pellet and pen formats for controlled, low-passage inoculation without the handling burden and drift risk of maintaining stocks in-house

Each is traceable to the source collection, so that six months after a test, you can reconstruct exactly which organism was used, where it came from, and how it was handled.

Why this matters to your programme

A perfectly characterised strain cannot rescue an uncontrolled test system — and an uncontrolled strain will quietly undermine an otherwise sound one. Reliable GPT is a chain: the right reference organism, appropriate media, a controlled inoculum, defined test conditions, clear acceptance criteria, and documentation that lets you defend every one of those choices. The reference strain is where that chain begins.

The right reference microorganism is not an afterthought. It is part of the measurement system.

One Partner. Your Complete Microbiology System.

[Talk to us about your reference strain and GPT requirements →]